Comment Of The Day: “Painkiller”

Most of the comments on EA posts come from a solid base of experience and knowledge, but it is especially welcome when a commenter enlightens us on a subject he or she really knows well. Thus Tom P.’s observations on the pharmaceutical industry in light of the EA post on the Perdue Pharma/Sackler/ OxyContin horror as dramatized in “Painkiller” is a special pleasure. Here it is, a Comment of the Day:

***

I apologize for the length of this post, but the topic is complicated and does not lend itself to sound bites. What follows is my experience and opinions based on working in the pharmaceutical industry and extensive reading on my part.

Full disclosure: I am a retired pharmaceutical company executive. During my career, I worked for various cosmetic and pharmaceutical companies. I held positions in R&D, manufacturing, quality control, and supply chain management. For most of my career, I was responsible for a major Pharma manufacturer’s anticancer and biologics global supply chains. As a point of reference, I have not seen “Dopesick” or “Painkiller”. I am familiar, however, with the travesty the Sacklers perpetrated on the sick and society. The best summary of their unethical and probably criminal behavior I have read is in an LA Times May 5, 2016, article: https://www.latimes.com/projects/oxycontin-part1/

Continue reading

“Painkiller”

“Painkiller,” the new Netflix series about the origins of the opioid crisis largely created by the despicable machinations of the Sackler family and Perdue Pharma, could not be better timed. Just three days ago there was another development in the fall of the Sacklers, as the U.S. Supreme Court temporarily blocked the implementation of the 2021 $6 billion deal in federal bankruptcy court that would have blocked future opioid lawsuits against family members, who added to their vast fortune by creating and peddling OxyContin to complicit doctors and unsuspecting members of the public.

OxyContin was introduced in 1995 as Purdue Pharma’s breakthrough drug for chronic pain. The company employed an unethical marketing strategy that family scion Arthur Sackler had pioneered decades earlier, lobbying doctors to prescribe the drug and increase its dosage by dangling gifts, free trips to “pain-management seminars,”( aka all-expenses-paid vacations), paid speaking engagements, and ego-stroking visits from comely sales reps with cheerleading credentials.

Continue reading